Progress Against Pancreatic Cancer. 1970–1979 Progress Against Pancreatic Cancer 1970–1979 1970s: Tobacco use found to cause pancreatic cancer.

Slides:



Advertisements
Similar presentations
Major Cancer Milestones
Advertisements

Progress Against Breast Cancer
Progress Against Prostate Cancer. 1970–1979 Progress Against Prostate Cancer 1970–1979 Early 1970s: Radioactive ''seeds'' proven effective for prostate.
Progress Against Lung Cancer. 1970–1979 Progress Against Lung Cancer 1970–1979 Mid-1970s: Chemotherapy combinations prove effective in small cell lung.
Progress Against Stomach Cancer. 1980–1989 Progress Against Stomach Cancer 1980– : Combination chemotherapy improves outcomes for advanced stomach.
Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970– : FDA approves doxorubicin, a vital part of combination chemotherapy.
Progress Against Bladder Cancer. Pre-1970 Progress Against Bladder Cancer Pre : Tool offers view inside bladder for first time.
Progress Against Ovarian Cancer. 1970–1979 Progress Against Ovarian Cancer 1970– : First effective combination chemotherapy regimen for ovarian.
Progress Against Testicular Cancer. 1970–1979 Progress Against Testicular Cancer 1970– : Two new drugs produce first complete remissions in advanced.
Progress Against Cervical Cancer. 1980–1989 Progress Against Cervical Cancer 1980– –1984: HPV virus is discovered to cause cervical cancer.
Progress Against Head and Neck Cancer. 1970–1979.
Progress Against Melanoma. 1970–1979 Progress Against Melanoma 1970– : Hereditary syndrome linked to increased melanoma risk.
Progress Against Leukemia. 1970–1979 Progress Against Leukemia 1970– : FDA approves doxorubicin.
Progress Against Kidney Cancer. 1970–1979 Progress Against Kidney Cancer 1970– : Removing just part of the cancerous kidney is proven safe and.
Progress Against Liver Cancer. 1970–1979 Progress Against Liver Cancer 1970– : First study finds chemotherapy effective for liver cancer.
Presenter Name(s) Issue date National Student.
CTOS Herman Suit CTOS Special Award Lecture November 2005 Professor Herman D Suit Massachusetts General Hospital Dept. of Radiation Oncology Boston.
Cardiovascular Disease In Women: Risk Factors
Di Riley Associate Director, Clinical Outcomes NCIN
Evaluation of Parenteral Nutrition Utilization in Oncology Patients
Trends in incidence and mortality, England 1989 to 2010.
Breast Cancer Early Detection is Your Best Protection
Advances and Emerging Therapy for Lung Cancer
Gynecologic Oncology Group Gynecologic Oncology Group Uterine Corpus Trials: GCIG David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Director and Dallas Foundation.
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Oncology and Palliative Care: Promoting the Comfort and Cure Model Parag Bharadwaj, MD FAAHPM.
Controversies in Adjuvant Therapy for Pancreatic Cancer Parag Sanghvi M.D. Tasha McDonald M.D. Department of Radiation Medicine OHSU.
MS&E 220 Project Yuan Xiang Chew, Elizabeth A Hastings, Morris Jinhui Zhang Probabilistic Analysis of Cervical Cancer Screening and Vaccination.
Cancer Clinical Trials: The Way We Make Progress Against Cancer.
The Facts about Breast Cancer
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Breast Cancer Detection, Treatment, and Survival in Medicare and Medicaid Insured Patients Cathy J. Bradley, Ph.D. Professor of Health Administration Co-leader,
By: Sydney Trecarichi, Hayley Cash and Jordan Wittig Esophageal Cancer.
Colorectal Cancer Center Jena Introduction In Germany, there are currently approximately newly diagnosed patients with colorectal carcinoma.
Eleni Galani Medical Oncologist
Breast Cancer Awareness By: Dominick Phillips. What Is Breast Cancer? If a cell changes into a abnormal, sometimes harmful form, it can divide quickly.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Treatment options depend on the following: – The stage of the cancer – Whether the cancer has recurred – The patient’s general health.
BME 301 Lecture Twenty-Two. How are health care technologies managed? Examples: MRI Laparoscopic cholecystectomy Vitamin C treatment for scurvy Research.
Todays Clinical Trials. Tomorrow’s Cures. Robert L. Comis, MD 1 National Coalition for Cancer Research “Cancer 101” Congressional Briefing 09/10/14.
Prepared By : Miss. Sana’a AL-Sulami Teacher Assistant.
The Colorectal Cancer Center Jena Gharbi A, Settmacher U. Department of General, Visceral and Vascular Surgery, Friedrich-Schiller-University Jena
Eric Van Cutsem Head, Digestive Oncology, University Hospital Gasthuisberg and Professor of Internal Medicine, University of Leuven, Belgium Published.
Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.
Recent Advances in Head and Neck Cancer Robert I. Haddad, M.D., and Dong M. Shin, M.D. The NEW ENGLAND JOURNAL of MEDICINE N Engl J Med 2008;359:
HER2 POSITIVE BREAST CARCINOMA IN THE PRE AND POST ADJUVANT ANTI-HER-2 THERAPY ERA: A SINGLE ACADEMIC INSTITUTION EXPERIENCE IN THE SETTING OUTSIDE OF.
Treatment Regimens of HER2+ Adjuvant Patients (Actuals) Source: Genentech ASCO 2005 (data release) Nov 2006 (Approval)
Pre-Operative Therapy for Borderline Resectable Pancreatic Cancer: The Potential Role of Chemotherapy Robert A. Wolff, M.D. Associate Professor of Medicine.
Neoadjuvant FOLFOX with Bevacizumab but without Pelvic Radiation for Locally Advanced Rectal Cancer Schrag D et al. Proc ASCO 2010;Abstract 3511.
Patterns of care and comparative effectiveness of endocrine therapy for premenopausal women with early breast cancer A multi-institution cohort study February.
R3 이운주/Prof 맹치훈. Introduction Pancreatic adenocarcinoma is most lethal cancer, with a 5-year survival rate of less than 5%. Relapsed occurs in 80-85%
Clinical and Research Updates in Gynecologic Oncology
Omega Best Cancer Hospital - India
The Uganda Cancer Institute Experience Walusansa Victoria.
PHEN Clinical Trials Rally
Colorectal Cancer Update Patient Perspectives on Colorectal Cancer
The Nurse View: Management of Pancreatic Cancer
From: Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 YearsA Comparative Modeling Study of Risk Ann Intern.
Cancer Cachexia in GI Malignancies
Changing the IBD Paradigm
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Prepared by staff in Prevention and Cancer Control.
Oncology Market Forecast
Potential clinical actionability.
Breast Cancer.
Treatment of Locally Advanced Pancreatic Cancer
A Guideline-Based Approach to HCV Care
Neoadjuvant Adjuvant Curative Palliative
Presentation transcript:

Progress Against Pancreatic Cancer

1970–1979

Progress Against Pancreatic Cancer 1970– s: Tobacco use found to cause pancreatic cancer

Progress Against Pancreatic Cancer 1970– : Modification of standard surgical technique leads to fewer complications for patients with early- stage pancreatic cancer

Progress Against Pancreatic Cancer 1980–1989

Progress Against Pancreatic Cancer 1980– : Chemotherapy plus radiation effective for patients who cannot be treated surgically

Progress Against Pancreatic Cancer 1980– : Chemotherapy plus radiation effective as adjuvant therapy

Progress Against Pancreatic Cancer 1990–1999

Progress Against Pancreatic Cancer 1990– s: New imaging techniques help doctors assess and identify which patients need more aggressive care

Progress Against Pancreatic Cancer 1990– : Gemcitabine modestly extends survival, relieves symptoms with advanced pancreatic cancer

Progress Against Pancreatic Cancer 2000–Present

Progress Against Pancreatic Cancer 2000–Present Mid-2000s: Screening program for people at high- risk can detect potentially operable pancreatic tumors 2004: Adjuvant chemotherapy shown to benefit patients with early pancreatic cancer

Progress Against Pancreatic Cancer 2000–Present 2005: First targeted drug approved for pancreatic cancer

Progress Against Pancreatic Cancer 2000–Present 2007–2008: Adjuvant gemcitabine further extends survival for patients with early pancreatic cancer

Progress Against Pancreatic Cancer 2000–Present 2008: Major study maps the pancreatic cancer genome

Progress Against Pancreatic Cancer 2000–Present 2010: New combination chemotherapy regimen extends advanced pancreatic cancer survival

Progress Against Pancreatic Cancer Five-Year Survival Source: National Cancer Institute

Progress Against Pancreatic Cancer Mortality Source: National Cancer Institute

Progress Against Pancreatic Cancer New Cases Source: National Cancer Institute

Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and research new cures

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.